Application of response surface methodology to maximize the productivity of scalable automated human embryonic stem cell manufacture
Cell therapy weekly: Stem cell therapy improves osteoarthritis quality of life by 290%
Cell therapy weekly: Positive outlook for oncology patients receiving immunotherapies
Reducing stem cell variability with automation for standardized treatments: an interview with NYSCF's Scott Noggle
Scaling human pluripotent stem cell expansion and differentiation: are cell factories becoming a reality?
Qualification of academic facilities for small-scale automated manufacture of autologous cell-based products